• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service.各国应该设定明确的医保福利套餐吗?以英国国民医疗服务体系为例。
Value Health. 2017 Jan;20(1):60-66. doi: 10.1016/j.jval.2016.01.004.
2
Universal Health Coverage and Essential Packages of Care全民健康覆盖与基本医疗服务包
3
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.基于绩效的风险分担安排——设计、实施和评估的良好实践:ISPOR 基于绩效的风险分担安排良好实践工作组的报告。
Value Health. 2013 Jul-Aug;16(5):703-19. doi: 10.1016/j.jval.2013.04.011. Epub 2013 Jul 19.
4
Searching for cost effectiveness thresholds in the NHS.在英国国家医疗服务体系中寻找成本效益阈值。
Health Policy. 2009 Aug;91(3):239-45. doi: 10.1016/j.healthpol.2008.12.010. Epub 2009 Jan 24.
5
Clarifying the scope of Italian NHS coverage. Is it feasible? Is it desirable?明确意大利国民健康服务(NHS)覆盖范围。这可行吗?可取吗?
Health Policy. 1999 Dec;50(1-2):123-42. doi: 10.1016/s0168-8510(99)00068-8.
6
How to develop cost-conscious guidelines.如何制定注重成本的指南。
Health Technol Assess. 2001;5(16):1-69. doi: 10.3310/hta5160.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Payment methods for healthcare providers working in outpatient healthcare settings.医疗机构中从事门诊医疗服务人员的付费方式。
Cochrane Database Syst Rev. 2021 Jan 20;1(1):CD011865. doi: 10.1002/14651858.CD011865.pub2.
9
Can we restrict the health care menu?我们能否限制医疗保健的选择范围?
Health Policy. 1994 Feb;27(2):103-12. doi: 10.1016/0168-8510(94)90075-2.
10
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.

引用本文的文献

1
Health benefits package selection in oncology: a clinical audit of palliative chemotherapy for breast cancer in an Indian health insurance scheme.肿瘤学中的健康福利套餐选择:对印度一项健康保险计划中乳腺癌姑息化疗的临床审计
BMC Health Serv Res. 2024 Dec 18;24(1):1591. doi: 10.1186/s12913-024-12018-4.
2
The impact of social, national and community-based health insurance on health care utilization for mental, neurological and substance-use disorders in low- and middle-income countries: a systematic review.社会、国家和社区医疗保险对低收入和中等收入国家精神、神经和物质使用障碍医疗保健利用的影响:一项系统评价
Health Econ Rev. 2020 Apr 24;10(1):11. doi: 10.1186/s13561-020-00268-x.
3
Are low and middle-income countries prioritising high-value healthcare interventions?中低收入国家是否优先考虑高价值的医疗干预措施?
BMJ Glob Health. 2020 Feb 4;5(2):e001850. doi: 10.1136/bmjgh-2019-001850. eCollection 2020.

本文引用的文献

1
Defining a Health Benefits Package: What Are the Necessary Processes?定义健康福利套餐:必要流程有哪些?
Health Syst Reform. 2016 Jan 2;2(1):39-50. doi: 10.1080/23288604.2016.1124171.
2
Departures from Cost-Effectiveness Recommendations: The Impact of Health System Constraints on Priority Setting.背离成本效益建议:卫生系统限制对优先事项设定的影响。
Health Syst Reform. 2016 Jan 2;2(1):61-70. doi: 10.1080/23288604.2015.1124170.
3
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.英国国家卫生与临床优化研究所成本效益阈值的估计方法。
Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140.
4
Where is the evidence for the existence of the Cancer Drugs Fund?癌症药物基金存在的证据在哪里?
BMJ. 2014 Sep 30;349:g5901. doi: 10.1136/bmj.g5901.
5
The Influence of Cost-Effectiveness and Other Factors on Nice Decisions.成本效益及其他因素对英国国家卫生与临床优化研究所决策的影响
Health Econ. 2015 Oct;24(10):1256-1271. doi: 10.1002/hec.3086. Epub 2014 Sep 23.
6
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.欧洲 1999-2007 年按国家和年龄划分的癌症生存情况:欧洲癌症与生存研究-5 的结果--一项基于人群的研究。
Lancet Oncol. 2014 Jan;15(1):23-34. doi: 10.1016/S1470-2045(13)70546-1. Epub 2013 Dec 5.
7
Access, affordability, and insurance complexity are often worse in the United States compared to ten other countries.与其他十个国家相比,美国在医疗服务可及性、可负担性和保险复杂性方面往往更差。
Health Aff (Millwood). 2013 Dec;32(12):2205-15. doi: 10.1377/hlthaff.2013.0879. Epub 2013 Nov 13.
8
NICE's end of life decision making scheme: impact on population health.英国国家卫生与临床优化研究所的临终决策方案:对人群健康的影响。
BMJ. 2013 Mar 21;346:f1363. doi: 10.1136/bmj.f1363.
9
Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.承认经济评估中的患者异质性:系统文献回顾。
Pharmacoeconomics. 2013 Feb;31(2):111-23. doi: 10.1007/s40273-012-0015-4.
10
Evaluation of clinical threshold policies for cataract surgery among English commissioners.评估英国医保决策人制定的白内障手术临床阈值政策。
J Health Serv Res Policy. 2012 Oct;17(4):241-7. doi: 10.1258/jhsrp.2012.012023. Epub 2012 Sep 11.

各国应该设定明确的医保福利套餐吗?以英国国民医疗服务体系为例。

Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service.

作者信息

Smith Peter C, Chalkidou Kalipso

机构信息

Imperial College Business School, London, UK.

Institute for Global Health Innovation, Imperial College, London, UK.

出版信息

Value Health. 2017 Jan;20(1):60-66. doi: 10.1016/j.jval.2016.01.004.

DOI:10.1016/j.jval.2016.01.004
PMID:28212971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5338874/
Abstract

BACKGROUND

A fundamental debate in the transition towards universal health coverage concerns whether to establish an explicit health benefits package to which all citizens are entitled, and the level of detail in which to specify that package. At one extreme, the treatments to be funded, and the circumstances in which patients qualify for the treatment, might be specified in great detail, and be entirely mandatory. This would make clinicians little more than automata, carrying out prescribed practice. At the other extreme, priorities may be expressed in very broad terms, with no compulsion or other incentives to encourage adherence.

OBJECTIVES

The paper examines the arguments for and against setting an explicit benefits package, and discusses the circumstances in which increased detail in specification are most appropriate.

METHODS

The English National Health Service is used as a case study, based on institutional history, official documents and research literature.

RESULTS

Although the English NHS does not explicitly specify a health benefits package, it is in some respects establishing an 'intelligent' package, based on instruments such as an essential medicines list, clinical guidelines, provider payment and performance reporting, which acknowledges gaps in evidence and variations in local resource constraints.

CONCLUSIONS

Further moves towards a more explicit specification are likely to yield substantial benefits in most health systems. Considerations in determining the 'hardness' of benefits package specification might include the quality of information about the costs and benefits of treatments, the heterogeneity of patient needs and preferences, the financing regime in place, and the nature of supply side constraints.

摘要

背景

在向全民健康覆盖转型的过程中,一个基本的争论涉及是否要制定一份所有公民都有权享受的明确的健康福利套餐,以及该套餐详细程度的问题。在一个极端情况下,可能会非常详细地规定要资助的治疗方法以及患者获得治疗资格的情况,并且完全具有强制性。这会使临床医生几乎变成自动执行规定操作的机器。在另一个极端,优先事项可能会以非常宽泛的术语来表达,没有强制要求或其他激励措施来鼓励遵循。

目的

本文审视了支持和反对设定明确福利套餐的论据,并讨论了在哪些情况下增加规定的详细程度最为合适。

方法

以英国国家医疗服务体系为例进行研究,依据机构历史、官方文件和研究文献。

结果

尽管英国国家医疗服务体系没有明确规定健康福利套餐,但在某些方面正在基于基本药物清单、临床指南、提供者支付和绩效报告等工具建立一个“智能”套餐,该套餐承认证据方面的差距以及当地资源限制的差异。

结论

在大多数卫生系统中,进一步朝着更明确的规定迈进可能会带来巨大益处。确定福利套餐规定“严格程度”时的考虑因素可能包括有关治疗成本和效益的信息质量、患者需求和偏好的异质性、现行的融资制度以及供应方限制的性质。